| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 32.02 mm | 32.02 mm | 32.02 mm | 32.02 mm | 32.02 mm | 32.02 mm |
| Cash burn (monthly) | 1.97 mm | 6.01 mm | 12.75 mm | 13.77 mm | 10.89 mm | 10.34 mm |
| Cash used (since last report) | 8.98 mm | 27.46 mm | 58.27 mm | 62.93 mm | 49.77 mm | 47.28 mm |
| Cash remaining | 23.03 mm | 4.55 mm | -26.25 mm | -30.91 mm | -17.75 mm | -15.26 mm |
| Runway (months of cash) | 11.7 | 0.8 | -2.1 | -2.2 | -1.6 | -1.5 |
| 13F holders | Current |
|---|---|
| Total holders | 131 |
| Opened positions | 18 |
| Closed positions | 30 |
| Increased positions | 43 |
| Reduced positions | 32 |
| 13F shares | Current |
|---|---|
| Total value | 101.76 bn |
| Total shares | 62.99 mm |
| Total puts | 70.70 k |
| Total calls | 147.70 k |
| Total put/call ratio | 0.5 |
| Largest owners | Shares | Value |
|---|---|---|
| BlackRock | 7.23 mm | $14.18 bn |
| PFE Pfizer | 4.69 mm | $19.93 mm |
| Vanguard | 4.62 mm | $9.05 bn |
| BAC Bank of America | 4.57 mm | $8.96 bn |
| Partner Fund Management | 4.31 mm | $8.44 bn |
| Rachel E. Haurwitz | 3.35 mm | $20.50 mm |
| Farallon Capital Partners | 2.58 mm | $41.11 mm |
| Kynam Capital Management | 2.36 mm | $4.62 bn |
| Elmwood Wealth Management | 2.18 mm | $4.26 bn |
| Point72 Asset Management | 2.13 mm | $4.18 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 29 Jan 25 | Ryali Sriram | Common Stock | Buy | Acquire P | No | No | 1.42 | 17,360 | 24.65 k | 17,360 |
| 10 Jan 25 | Ryali Sriram | Option to purchase Common Stock Common Stock | Grant | Acquire A | No | No | 1.64 | 300,000 | 492.00 k | 300,000 |
| 20 Nov 24 | Ryan Fischesser | Common Stock | Grant | Acquire A | No | No | 0 | 25,000 | 0.00 | 118,854 |
